Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

Hecht, J. R.; Raman, S. S.; Chan, A.; Kalinsky, K.; Baurain, J. -F.; Jimenez, M. M.; Garcia, M. M.; Berger, M. D.; Lauer, U. M.; Khattak, A.; Carrato, A.; Zhang, Y.; Liu, K.; Cha, E.; Keegan, A.; Bhatta, S.; Strassburg, C. P.; Roohullah, A.

dc.contributor.author	Lauer, Ulrich Manfred
dc.date.accessioned	2024-05-14T10:15:25Z
dc.date.available	2024-05-14T10:15:25Z
dc.date.issued	2023
dc.identifier.issn	2059-7029
dc.identifier.uri	http://hdl.handle.net/10900/153351
dc.language.iso	en	de_DE
dc.publisher	Amsterdam : Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.esmoop.2023.100884	de_DE
dc.subject.ddc	610	de_DE
dc.title	Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230928000000_02317
utue.personen.roh	Hecht, J. R.
utue.personen.roh	Raman, S. S.
utue.personen.roh	Chan, A.
utue.personen.roh	Kalinsky, K.
utue.personen.roh	Baurain, J. -F.
utue.personen.roh	Jimenez, M. M.
utue.personen.roh	Garcia, M. M.
utue.personen.roh	Berger, M. D.
utue.personen.roh	Lauer, U. M.
utue.personen.roh	Khattak, A.
utue.personen.roh	Carrato, A.
utue.personen.roh	Zhang, Y.
utue.personen.roh	Liu, K.
utue.personen.roh	Cha, E.
utue.personen.roh	Keegan, A.
utue.personen.roh	Bhatta, S.
utue.personen.roh	Strassburg, C. P.
utue.personen.roh	Roohullah, A.
dcterms.isPartOf.ZSTitelID	Esmo Open	de_DE
dcterms.isPartOf.ZS-Issue	Article 100884	de_DE
dcterms.isPartOf.ZS-Volume	8 (2)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE